Monday, October 26, 2026 · Daily editionET --:--:--

Under way, not recruiting

Robotic vs. Conventional Minimal-invasive Inguinal Hernia Repair

NCT05216276 · University Hospital, Basel, Switzerland · Updated 28 Jan 2025

What is being tested
TEP; rTAPP
For
Hernia, Inguinal; Robotic Surgical Procedures
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 182 people. The full rules are on the registry page.
Where
Switzerland
When
Starts or started 17 Jan 2022, ends 31 Dec 2025. Registered 31 Jan 2022.
Results
None posted yet.

In the researchers' words

Minimal invasive techniques have become a well established approach for inguinal hernia repair over the last decade in developed countries. Different techniques such as total extraperitoneal endoscopic hernioplasty (TEP) and transabdominal preperitoneal hernia repair (TAPP) have been described. These studies show comparable results in short and long term outcome. Robotic inguinal hernia surgery enables an even more precise dissection within the preperitoneal layer thus preserving the nerves of the lateral abdominal wall. This may translate into a reduced level of acute and chronic postoperative pain as previously reported by retrospective case series. The role of robotic surgery for inguinal hernia repair in regard of postoperative pain and recovery has not been investigated in randomized and blinded clinical studies yet. With this randomized and blinded trial the investigators compare robotic TAPP (rTAPP) to conventional TEP with a decreased pain level shortly after surgery as primary outcome (numeric rating scale - NRS). A reduced postoperative NRS for pain may translate into faster recovery and less chronic pain, secondary endpoints include comparison of pain in a longer course (short-form inguinal pain questionnaire (sf-IPQ)), quality of life / health status (Baseline Short Form-12 (SF-12), Carolinas Comfort Scale (CCS)), complications (Comprehensive Complication Index -…
ClinicalTrials.gov, NCT05216276

Sites

  • Clarunis AGBasel, Basel-Landschaft, Switzerland